Protective effect of modified glucomannans against aurofusarin-induced changes in quail egg and embryo.
The aim of this study was to evaluate effects of modified glucomannans (Mycosorb) on egg yolk and liver of the day-old quail after aurofusarin inclusion in the maternal diet. Fifty-four 45-day-old Japanese quail were divided into three groups and were fed ad libitum a corn-soya diet balanced in all nutrients. The diet of the experimental quail was supplemented with aurofusarin at the level of 26.4 mg/kg feed in the form of Fusarium graminearum culture enriched with aurofusarin or with aurofusarin plus Mycosorb at 1 g/kg feed. Eggs obtained after 8 weeks of feeding were analysed and incubated in standard conditions of 37.5 degrees C/55% RH. Samples of quail liver were collected from day-old hatchlings. Main polyunsaturated fatty acids (PUFAs) of the egg yolk were analysed by gas chromatography, and tocopherols and tocotrienols were analysed by HPLC-based methods. Inclusion of aurofusarin in the maternal diet was associated with decreased proportions of docosahexaenoic acid and increased proportions of linoleic acid in major lipid fractions of the egg yolk as well as with decreased concentrations of alpha- and gamma-tocopherols, alpha- and gamma-tocotrienols in egg yolk and liver of a day-old quail. Inclusion of modified glucomannans (Mycosorb) into the quail diet simultaneously with aurofusarin showed a significant protective effect against changes in PUFA and antioxidant composition in the egg yolk and liver of quail. It is suggested that a combination of mycotoxin adsorbents and natural antioxidants could be the next step in counteracting mycotoxins in animal feed.
Dvorska
Julia E
JE
Sumy National Agrarian University, Sumy, Ukraine.
Surai
Peter F
PF
Speake
Brian K
BK
Sparks
Nick H C
NH
D000818:Animals; D003370:Coturnix / Q000196:embryology* / Q000378:metabolism; D004530:Egg Yolk / Q000187:drug effects / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008351:Mannans / Q000494:pharmacology*; D009285:Naphthoquinones / Q000037:antagonists & inhibitors / Q000633:toxicity*; D010063:Ovum / Q000187:drug effects* / Q000378:metabolism; D014810:Vitamin E / Q000378:metabolism
D005230:Fatty Acids, Nonesterified; D008351:Mannans; D009285:Naphthoquinones; D014810:Vitamin E; C022901:(1-6)-alpha-glucomannan; C083578:aurofusarin